Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Thaker

Showing results (101-110 of 256) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancersSummer B Dewdney, B J Rimel, Premal H Thaker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 14, 2014
Etiology and workup of fevers in gynecologic oncology patientsStephen A McCartney, Michelle C Sabo, L Stewart Massad, et al.
Psychoneuroendocrinology|July 17, 2017
Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancerMichaela G Cuneo, Andrew Schrepf, George M Slavich, et al.
Gynecologic Oncology|October 8, 2013
Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancerAndrea R Hagemann, Akiva P Novetsky, Israel Zighelboim, et al.
Psycho-Oncology|March 24, 2021
Chronic difficulties are associated with poorer psychosocial functioning in the first year post-diagnosis in epithelial ovarian cancer patientsLauren Garvin, George M Slavich, Andrew Schrepf, et al.
Obstetrics and Gynecology|October 10, 2013
Disclosing a diagnosis of cancer: considerations specific to gynecologic oncology patientsLindsay M Kuroki, Qiuhong Zhao, Donna B Jeffe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 7, 2024
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
Gynecologic Oncology|February 1, 2024
Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targetsLeah McNally, Sharon Wu, Kurt Hodges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomesIsrael Zighelboim, Amy P Schmidt, Feng Gao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
Pageof 26

Showing results (101-110 of 256) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancersSummer B Dewdney, B J Rimel, Premal H Thaker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 14, 2014
Etiology and workup of fevers in gynecologic oncology patientsStephen A McCartney, Michelle C Sabo, L Stewart Massad, et al.
Psychoneuroendocrinology|July 17, 2017
Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancerMichaela G Cuneo, Andrew Schrepf, George M Slavich, et al.
Gynecologic Oncology|October 8, 2013
Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancerAndrea R Hagemann, Akiva P Novetsky, Israel Zighelboim, et al.
Psycho-Oncology|March 24, 2021
Chronic difficulties are associated with poorer psychosocial functioning in the first year post-diagnosis in epithelial ovarian cancer patientsLauren Garvin, George M Slavich, Andrew Schrepf, et al.
Obstetrics and Gynecology|October 10, 2013
Disclosing a diagnosis of cancer: considerations specific to gynecologic oncology patientsLindsay M Kuroki, Qiuhong Zhao, Donna B Jeffe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 7, 2024
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
Gynecologic Oncology|February 1, 2024
Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targetsLeah McNally, Sharon Wu, Kurt Hodges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomesIsrael Zighelboim, Amy P Schmidt, Feng Gao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
Pageof 26